Collection of Pharmacogenomics (PGx) Results and Clinical Data of Aging Poly-Pharm Patients of the Individualized Medicine Clinic to Assess Current and Future Therapeutic Relevance

Overview

About this study

The purpose of this study is to learn more about how individuals break down and process their medications based on their genes.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

A Mayo Clinic patient with a Mayo Clinic Provider that is piloting PGx testing with the Center for Individualized Medicine
Patient age of 65 years or older
Patient currently taking (or should be) or more prescription medications in 3 or more drug classes impacted by the chosen panel test’s genes. The drug classes include:
- Antidepressants (SSRIs, SNRIs, TCAs)
- Pain (Codeine, Tramadol, TCA)
- Anticoagulants and Antiplatelet (Warfarin, Clopidogrel)
Patients must understand and provide written informed consent and HIPAA authorization prior to initiation of any study-specific procedure

Exclusion Criteria:

Patients with a diagnosis of psychotic disorders, bipolar disorders, active substance use disorders or those who have or develop suicidal ideation per their medical record.
Patients with previous Pharmacogenomics testing.
Patients consented under the Right or Right10K studies.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Konstantinos Lazaridis, M.D.	Closed for enrollment	Contact information: Center for Individualized Medicine (507)293-0792

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Konstantinos Lazaridis, M.D.

Closed for enrollment

Contact information:

Center for Individualized Medicine

(507)293-0792

More information

Publications

Publications are currently not available

Clinical Trials